In this context, it may be more straightforward to develop novel drugs which are not transported by P-glycoprotein/ABCB1 and therefore bear the potential to kill multidrug-resistant tumor cells with similar efficacy to otherwise drug-sensitive cells. This evidence concerns the gene ABCB1 and neoplasm.